In a real-world study at Oslo University Hospital, ERCP was assessed as the initial management for malignant biliary obstruction (MBO). Of 596 patients, the primary outcome was achieved in 62%, with an 80% overall technical success rate. Distal extrahepatic MBO had an 85% success rate. Reinterventions were performed in 27%, and complications occurred in 15%, including post-ERCP pancreatitis in 9%. The study concludes that ERCP is a valid first-line option for managing MBO, showcasing high clinical effectiveness and technical success.
Journal Article by Mikalsen IM, Breder S (…) Ånonsen KV et 3 al. in Scand J Gastroenterol